82 related articles for article (PubMed ID: 2061610)
1. Generation of antibodies against recombinant HIV-gp120 antigen through a novel immunization procedure.
Matour DL; Clark RK; Jonak ZL
J Immunol Methods; 1991 Jun; 140(1):135-8. PubMed ID: 2061610
[No Abstract] [Full Text] [Related]
2. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
3. Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120.
Peet NM; McKeating JA; Ramos B; Klonisch T; De Souza JB; Delves PJ; Lund T
Clin Exp Immunol; 1997 Aug; 109(2):226-32. PubMed ID: 9276516
[TBL] [Abstract][Full Text] [Related]
4. Anti-idiotypic antibodies to the third variable domain of gp120 induce an anti-HIV-1 antibody response in mice.
Boudet F; Theze J; Zouali M
Virology; 1994 Apr; 200(1):176-88. PubMed ID: 7510435
[TBL] [Abstract][Full Text] [Related]
5. Discontinuous epitopes on gp120 important in HIV-1 neutralization.
Ho DD; Fung MS; Yoshiyama H; Cao Y; Robinson JE
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1337-9. PubMed ID: 1281654
[No Abstract] [Full Text] [Related]
6. Mucosal immunity to HIV-1: systemic and vaginal antibody responses after intranasal immunization with the HIV-1 C4/V3 peptide T1SP10 MN(A).
Staats HF; Nichols WG; Palker TJ
J Immunol; 1996 Jul; 157(1):462-72. PubMed ID: 8683152
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
Bower JF; Green TD; Ross TM
Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
[TBL] [Abstract][Full Text] [Related]
8. Dual specificity of a monoclonal anti-idiotypic antibody for HIV-1 neutralizing monoclonals 110.3 and 110.4 as well as the V3 loop of gp120.
Connelly RJ; Kahn M; Blake J; Haffar OK; Thomas EK
Virology; 1994 Dec; 205(2):554-7. PubMed ID: 7526543
[TBL] [Abstract][Full Text] [Related]
9. Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.
Zolla-Pazner S; Powell R; Yahyaei S; Williams C; Jiang X; Li W; Lu S; Wang S; Upadhyay C; Hioe CE; Totrov M; Kong X
J Virol; 2016 Dec; 90(24):10993-11006. PubMed ID: 27630234
[TBL] [Abstract][Full Text] [Related]
10. Multiepitope polypeptide of the HIV-1 envelope induces neutralizing monoclonal antibodies against V3 loop.
Duarte CA; Montero M; Seralena A; Valdés R; Jiménez V; Benítez J; Narciandi E; Madrazo J; Padrón G; Sánchez G
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):235-43. PubMed ID: 7517147
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response to immunocomplexed HIV envelope glycoprotein 120.
Denisova G; Stern B; Raviv D; Zwickel J; Smorodinsky NI; Gershoni JM
AIDS Res Hum Retroviruses; 1996 Jul; 12(10):901-9. PubMed ID: 8798975
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of immunoadjuvant conjugates with HIV-derived peptide inducing peptide-specific antibody.
Maruyama Y; Kurimura M; Achiwa K
Chem Pharm Bull (Tokyo); 1994 Aug; 42(8):1709-11. PubMed ID: 7954925
[No Abstract] [Full Text] [Related]
13. Sequential immunizations with rgp120s from independent isolates of human immunodeficiency virus type 1 induce the preferential expansion of broadly crossreactive B cells.
Klinman DM; Higgins KW; Conover J
J Exp Med; 1991 Apr; 173(4):881-7. PubMed ID: 2007856
[TBL] [Abstract][Full Text] [Related]
14. Design of a complete synthetic peptide-based AIDS vaccine with a built-in adjuvant.
Nardelli B; Defoort JP; Huang W; Tam JP
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1405-7. PubMed ID: 1466968
[No Abstract] [Full Text] [Related]
15. Adjuvanticity of stearyl tyrosine on the antibody response to peptide 503-535 from HIV gp160.
Nixon A; Zaghouani H; Penney CL; Lacroix M; Dionne G; Anderson SA; Kennedy RC; Bona CA
Viral Immunol; 1992; 5(2):141-50. PubMed ID: 1616585
[TBL] [Abstract][Full Text] [Related]
16. Immunization of primates with native, recombinant HIV-SF2 gp120 generates broadly effective neutralizing antibodies directed to conformational epitopes.
Steimer KS; Haigwood NL
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1391. PubMed ID: 1281658
[No Abstract] [Full Text] [Related]
17. Polyclonal antiidiotypic antibodies mimicking gp120 of HIV-1.
Sperlagh M; Hoxie J; Maruyama H; Stefano K; Gonzales-Scarano F; Prewett M; Liang S; Matsushita S; Herlyn D
Viral Immunol; 1994; 7(2):61-9. PubMed ID: 7531443
[TBL] [Abstract][Full Text] [Related]
18. Vaginal immunization of rats with a synthetic peptide from human immunodeficiency virus envelope glycoprotein.
O'Hagan DT; Rafferty D; McKeating JA; Illum L
J Gen Virol; 1992 Aug; 73 ( Pt 8)():2141-5. PubMed ID: 1645152
[TBL] [Abstract][Full Text] [Related]
19. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
[No Abstract] [Full Text] [Related]
20. Type-specific and cross-reactive neutralizing antisera against HIV elicited by V3-peptide heptalysine octomers.
Looney DJ; Li M; Walfield A; Hosein B; Badel P; Wang CY; Wong-Staal F
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1381. PubMed ID: 1466961
[No Abstract] [Full Text] [Related]
[Next] [New Search]
